| scholarly article | Q13442814 |
| P50 | author | Eric Vittinghoff | Q37323613 |
| P2093 | author name string | Robert H Lustig | |
| Neera Gupta | |||
| Michael A Kohn | |||
| Marjorie McCracken | |||
| P2860 | cites work | Association of Linear Growth Impairment in Pediatric Crohn's Disease and a Known Height Locus: A Pilot Study | Q24630823 |
| Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man | Q28248505 | ||
| TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding | Q28366349 | ||
| Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children | Q33941702 | ||
| Estrogen, bone, growth and sex: a sea change in conventional wisdom. | Q34153760 | ||
| Nutritional regulation of the insulin-like growth factors | Q34339433 | ||
| Growth and clinical course of children with Crohn's disease | Q34376822 | ||
| Nyctohemeral growth hormone levels in children with growth retardation and inflammatory bowel disease , | Q34475916 | ||
| Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha | Q37011469 | ||
| Guidelines for the management of growth failure in childhood inflammatory bowel disease | Q37081554 | ||
| Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation | Q37363276 | ||
| Mechanisms of growth impairment in pediatric Crohn's disease | Q37588490 | ||
| Basal and Stimulated Serum Growth Hormone Concentrations in Inflammatory Bowel Disease | Q39140579 | ||
| Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis | Q40424076 | ||
| Risk factors for initial surgery in pediatric patients with Crohn's disease. | Q40481272 | ||
| Development and validation of a pediatric Crohn's disease activity index | Q40749458 | ||
| A case of apparent hypopituitarism complicating chronic inflammatory bowel disease in childhood and adolescence | Q40806409 | ||
| Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line | Q40859741 | ||
| Tumor necrosis factor-alpha inhibits growth hormone secretion from cultured anterior pituitary cells | Q41317039 | ||
| Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture | Q42435114 | ||
| Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1beta in vitro | Q42493242 | ||
| Delayed puberty and response to testosterone in a rat model of colitis | Q43771171 | ||
| Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease | Q44478473 | ||
| Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents | Q45173646 | ||
| Bone health in children with inflammatory bowel disease: adjusting for bone age. | Q45891846 | ||
| Growth failure in children and adolescents with Crohn's disease. | Q46069705 | ||
| Gender differences in presentation and course of disease in pediatric patients with Crohn disease | Q46153034 | ||
| Urinary excretion of human growth hormone in children with short stature: Correlation with pituitary secretion of human growth hormone | Q48532167 | ||
| Adenohypophyseal and sex hormones in pediatric rheumatic diseases. | Q51053604 | ||
| Chronic regional enteritis and growth retardation. | Q52356877 | ||
| Infliximab reverses growth hormone resistance associated with inflammatory bowel disease | Q59310001 | ||
| Relationships between Serum IGF-1, IGFBP-2, Interleukin-1Beta and Interleukin-6 in Inflammatory Bowel Disease | Q62116658 | ||
| Urinary growth hormone (GH) measurements are useful for evaluating endogenous GH secretion | Q68140130 | ||
| Abnormalities of sex hormones in men with systemic lupus erythematosus | Q69786369 | ||
| Endocrine dysfunction in children with Crohn's disease | Q70382899 | ||
| The reproductive endocrine system in cystic fibrosis. I. Basal gonadotropin and sex steroid levels | Q70782156 | ||
| Salivary testosterone levels in male adolescents with cystic fibrosis | Q71008138 | ||
| Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor | Q71597507 | ||
| Urinary growth hormone in growth-impaired children with chronic inflammatory bowel disease | Q72210515 | ||
| Growth failure in children with inflammatory bowel disease: a prospective study | Q72898882 | ||
| Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells | Q73050730 | ||
| Growth, body composition, and nutritional status in children and adolescents with Crohn's disease | Q74005426 | ||
| Reduced levels of testosterone and dehydroepiandrosterone sulphate in the serum and synovial fluid of juvenile rheumatoid arthritis patients correlates with disease severity | Q77653136 | ||
| Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity | Q80945570 | ||
| The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease | Q81024332 | ||
| Nutritional status and growth in pediatric Crohn's disease: a population-based study | Q82849298 | ||
| Natural history of Crohn's disease: comparison between childhood- and adult-onset disease | Q84736371 | ||
| Validation of a self-administered instrument to assess stage of adolescent development | Q86912908 | ||
| P433 | issue | 11 | |
| P921 | main subject | Crohn's disease | Q1472 |
| P304 | page(s) | 2318-2325 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
| P1476 | title | Sex differences in statural growth impairment in Crohn's disease: role of IGF-1. | |
| P478 | volume | 17 |
| Q30393825 | Catch-up growth occurs after diarrhea in early childhood |
| Q30412194 | Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn's disease: despite temporal changes in disease severity, the need for monitoring remains |
| Q46665586 | Determination of bone age in pediatric patients with Crohn's disease should become part of routine care |
| Q34587752 | Estrogen-IGF-1 interactions in neuroprotection: ischemic stroke as a case study |
| Q55112474 | Final adult height of patients with childhood-onset systemic lupus erythematosus: a cross sectional analysis. |
| Q34426164 | Growth problems in children with IBD. |
| Q50062805 | Increases in IGF-1 after Anti-TNF-α Therapy are Associated with Bone and Muscle Accrual in Pediatric Crohn's Disease |
| Q35186280 | Insulin-like growth factor I (IGF-1) deficiency ameliorates sex difference in cardiac contractile function and intracellular Ca(2+) homeostasis |
| Q90452801 | Introduction to and Screening Visit Results of the Multicenter Pediatric Crohn's Disease Growth Study |
| Q57451004 | Mechanisms and management of growth impairment in children affected by inflammatory bowel disease |
| Q46003243 | Menarche in pediatric patients with Crohn's disease. |
| Q30252705 | Mice with infectious colitis exhibit linear growth failure and subsequent catch-up growth related to systemic inflammation and IGF-1. |
| Q37467578 | NASPGHAN single-topic symposium: discovering the future of pediatric IBD care |
| Q46470367 | Report of the CCFA pediatric bone, growth and muscle health workshop, New York City, November 11-12, 2011, with updates |
| Q30275779 | Systemic inflammation, growth factors, and linear growth in the setting of infection and malnutrition |
| Q54958011 | Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn's disease. |
Search more.